OR2M3 Antibody

What is OR2M3 and what cellular functions does it perform?

OR2M3 is a member of the olfactory receptor family encoded by the OR2M3 gene (Gene ID: 127062) in humans. It functions as an odorant receptor within the large family of G-protein-coupled receptors (GPCRs) and arises from single coding-exon genes . OR2M3 shares a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and is responsible for the recognition and G protein-mediated transduction of odorant signals . A distinctive feature of OR2M3 is its copper binding pocket, which plays a critical role in its function . The protein is primarily localized in the cell membrane as a multi-pass membrane protein . Its primary function is initiating neuronal responses that trigger the perception of specific odors, particularly responding to 3-Mercapto-2-methylpentan-1-ol, which is associated with the characteristic smell of raw onions .

What research applications are OR2M3 antibodies suitable for?

Based on multiple commercial sources, OR2M3 antibodies have been validated for several research applications:

When selecting an OR2M3 antibody, researchers should consider the specific application requirements. For immunofluorescence studies, the antibody from St John's Laboratory has been validated to detect endogenous levels of OR2M3 protein . For protein quantification and expression studies, Western blot applications using the Abbexa antibody can be effective with the recommended dilution . Flow cytometry applications require higher concentrations (lower dilutions) due to the nature of the technique and typically provide information about protein expression in intact cells . ELISA applications usually require much higher dilutions due to the high sensitivity of the assay .

What are the critical storage and handling considerations for maintaining OR2M3 antibody activity?

Proper storage and handling of OR2M3 antibodies are essential for maintaining their activity and specificity. According to manufacturer recommendations, OR2M3 antibodies should be stored at -20°C for up to 1 year from the date of receipt . It is crucial to avoid repeated freeze-thaw cycles as these can degrade antibody quality and reduce binding affinity .

For optimal preservation of activity:

• Store in small aliquots to minimize freeze-thaw cycles

• Ensure the antibody remains in the recommended buffer conditions (typically PBS containing preservatives like sodium azide)

• Follow manufacturer's specific formulation requirements, such as the St John's Laboratory formulation in PBS containing 50% Glycerol, 0.5% BSA, and 0.02% Sodium Azide

• When working with the antibody, maintain cold chain protocols and return unused portions to -20°C promptly

• Monitor expiration dates and quality control parameters provided by manufacturers

How should researchers optimize OR2M3 antibody protocols for immunofluorescence studies?

Optimizing immunofluorescence protocols for OR2M3 detection requires careful consideration of several parameters:

Sample Preparation:

• For tissue sections: Fixation method significantly impacts epitope accessibility. Paraformaldehyde (4%) is generally recommended, but pilot studies comparing different fixatives may be necessary.

• For cultured cells: Consider both paraformaldehyde and methanol fixation, as the 7-transmembrane structure of OR2M3 may require specific conditions for optimal epitope exposure.

Antibody Optimization:

• Initial titration experiments should test a range of dilutions, starting with manufacturer recommendations (1:200-1:1000)

• Include positive controls (tissues/cells known to express OR2M3) and negative controls (tissues/cells without OR2M3 expression and secondary antibody-only controls)

• For double-staining protocols, ensure antibody compatibility and minimize cross-reactivity

• Consider epitope retrieval methods if initial results show weak signal

Signal Detection Enhancement:

• Implement tyramide signal amplification if standard protocols yield insufficient signal

• Use confocal microscopy for improved resolution of membrane localization

• Consider super-resolution techniques for detailed receptor distribution analysis

Given the polyclonal nature of available OR2M3 antibodies, batch testing is recommended to ensure consistent results across experiments .

What validation approaches should be employed to confirm OR2M3 antibody specificity?

Rigorous validation of OR2M3 antibody specificity is critical for reliable research outcomes:

Molecular Validation Approaches:

• Western blot validation: Confirm single band at the expected molecular weight (calculated MW: 34.8 kDa)

• Peptide competition assays: Pre-incubation with the immunizing peptide should abolish specific signal

• Knockout/knockdown controls: Compare staining patterns in OR2M3-expressing versus OR2M3-depleted samples

• Heterologous expression systems: Overexpress tagged OR2M3 and confirm co-localization of tag and antibody signals

Technical Validation Considerations:

• Cross-species reactivity testing: Available OR2M3 antibodies have varying species reactivity (Human only versus Human/Rat/Mouse )

• Epitope mapping: The St John's Laboratory antibody targets amino acids 241-290 , while the Abbexa antibody targets amino acids 244-272 , allowing for complementary validation approaches

• Application-specific validation: An antibody working well in one application may not perform optimally in others

A comprehensive validation strategy should incorporate multiple approaches rather than relying on a single validation method.

How can researchers utilize OR2M3 antibodies to investigate olfactory signaling mechanisms?

OR2M3 antibodies can be powerful tools for elucidating olfactory signaling pathways through several methodological approaches:

Co-localization Studies:

• Combine OR2M3 antibodies with markers for downstream signaling components (G proteins, adenylyl cyclase) to map the spatial organization of the signaling complex

• Dual-labeling with endosomal markers can track receptor internalization following odorant binding

Functional Analysis:

• Use OR2M3 antibodies in immunoprecipitation studies to identify novel protein interaction partners

• Combine with calcium imaging to correlate receptor expression with functional responses to 3-Mercapto-2-methylpentan-1-ol

• Develop proximity ligation assays to detect direct protein-protein interactions in situ

Tissue Distribution Analysis:

• Employ OR2M3 antibodies for comparative expression studies across different olfactory tissues

• Investigate potential expression in non-olfactory tissues, building on observations from OR2L13 studies that revealed unexpected roles for olfactory receptors in platelets

These approaches can be particularly valuable given recent discoveries about olfactory receptors having functions beyond olfaction, as demonstrated in the case of OR2L13 activation in platelets .

What are the key considerations when troubleshooting weak or absent signals in OR2M3 Western blotting?

Western blotting for OR2M3 can present challenges due to the protein's transmembrane nature. When troubleshooting weak or absent signals:

Sample Preparation Optimization:

• Membrane protein extraction protocols: Standard RIPA buffers may be insufficient; consider specialized membrane protein extraction kits

• Avoid sample heating above 70°C, as GPCR proteins often aggregate at higher temperatures

• Include protease inhibitors to prevent degradation during extraction

• Use fresh samples when possible, as membrane proteins can degrade during storage

Technical Adjustments:

• Transfer optimization: Extend transfer time or use specialized transfer methods for hydrophobic proteins

• Blocking optimization: Test BSA versus milk-based blocking solutions (BSA is often preferred for phospho-specific detection)

• Incubation conditions: Extended primary antibody incubation at 4°C (overnight or longer) may improve signal

• Detection system: Consider high-sensitivity ECL substrates or alternative detection methods

Controls and Troubleshooting:

• Positive control: Include a sample known to express OR2M3 at detectable levels

• Membrane staining: Verify successful protein transfer using reversible membrane stains

• Loading control selection: Choose appropriate loading controls for membrane proteins (Na⁺/K⁺-ATPase rather than cytosolic proteins)

When working with the recommended 1:1000 dilution for Western blot applications , researchers should still conduct optimization tests for their specific experimental conditions.

How can OR2M3 antibodies contribute to studies on ectopic olfactory receptor expression?

Recent research has revealed that olfactory receptors like OR2M3 may have functions beyond their classical role in olfaction. OR2M3 antibodies can be instrumental in exploring these novel areas:

Detection in Non-Olfactory Tissues:

• Systematic screening of tissues using validated OR2M3 antibodies can identify previously unknown sites of expression

• Multi-omics integration: Combine antibody-based detection with transcriptomic data to confirm protein expression in tissues showing OR2M3 mRNA

Functional Characterization:

• Similar to studies on OR2L13 in platelets , OR2M3 antibodies can help investigate potential roles in other cell types

• Neutralizing applications: Antibodies can potentially block receptor function to assess physiological roles

Pathological Relevance:

• Expression profiling in disease states may reveal dysregulation of OR2M3 in conditions not previously associated with olfactory function

• Cancer research applications: Several olfactory receptors show altered expression in various cancer types

This research direction is supported by findings that other olfactory receptors like OR2L13 play unexpected roles in non-olfactory tissues, such as limiting platelet reactivity .

What experimental approaches can distinguish between OR2M3 and closely related olfactory receptors?

The olfactory receptor family is extremely large with significant sequence homology, making specific detection challenging. When working with OR2M3 antibodies:

Antibody Selection Considerations:

• Review the immunogen sequence carefully: The St John's Laboratory antibody was raised against amino acids 241-290 , while the Abbexa antibody targets amino acids 244-272

• Compare these sequences against closely related receptors (OR2M6, OR1-54) to assess potential cross-reactivity

Validation Strategies:

• Recombinant protein panels: Test antibody reactivity against purified OR2M3 versus related proteins

• Competitive binding assays: Determine whether unlabeled antibodies compete for binding sites

• Absorption controls: Pre-absorb antibodies with related receptor peptides to remove cross-reactive antibodies

Analytical Approaches:

• High-resolution techniques like mass spectrometry following immunoprecipitation can confirm the precise identity of captured proteins

• Combined antibody approaches: Using antibodies targeting different epitopes can increase confidence in detection specificity

Researchers should be aware that OR2M3 has several alternative names (OR1-54, OR2M3P, OR2M6, OST003) , which may create confusion in the literature and when selecting appropriate controls.

How do different fixation methods affect OR2M3 epitope accessibility for immunostaining?

The 7-transmembrane structure of OR2M3 makes epitope accessibility particularly sensitive to fixation methods. Researchers should consider:

Impact of Common Fixatives:

• Paraformaldehyde (PFA): Preserves morphology but may mask transmembrane epitopes

• Methanol: Better permeabilization of membranes but can denature certain conformational epitopes

• Acetone: Rapid fixation that may better preserve certain epitopes but with poorer morphological preservation

• Glutaraldehyde: Strong cross-linking that typically reduces epitope accessibility

Optimization Recommendations:

• Conduct systematic comparisons of fixation methods using consistent antibody concentrations

• Consider dual fixation approaches (brief PFA followed by methanol) to balance morphology and accessibility

• Test timing variations: Brief fixation may preserve epitopes better than extended protocols

• Evaluate commercially available fixatives designed specifically for membrane proteins

Epitope Retrieval Strategies:

• Heat-induced epitope retrieval using citrate or EDTA buffers

• Enzymatic retrieval using proteases like pepsin or trypsin

• Detergent-based permeabilization optimization (Triton X-100, Tween-20, saponin)

Given that available OR2M3 antibodies target C-terminal regions (amino acids 241-290 or 244-272 ), these epitopes may be particularly sensitive to fixation-induced conformational changes.

What emerging technologies could enhance OR2M3 antibody applications in olfactory research?

Several cutting-edge technologies show promise for advancing OR2M3 antibody applications:

Advanced Imaging Technologies:

• Super-resolution microscopy techniques (STED, PALM, STORM) can resolve receptor distribution at nanoscale resolution

• Light-sheet microscopy for 3D visualization of OR2M3 distribution in whole tissues

• Expansion microscopy to physically enlarge samples for improved visualization of receptor clustering

Single-Cell Applications:

• Integration with single-cell RNA-seq data to correlate protein expression with transcriptional profiles

• Mass cytometry (CyTOF) with metal-conjugated OR2M3 antibodies for high-dimensional analysis

• Microfluidic-based single-cell Western blotting for quantitative protein analysis

In Vivo Applications:

• Development of OR2M3-targeted nanobodies for improved tissue penetration

• Near-infrared fluorophore conjugation for in vivo imaging applications

• Antibody engineering to generate bispecific antibodies targeting OR2M3 and downstream signaling partners

These technologies could significantly enhance our understanding of OR2M3's role in both olfactory and non-olfactory tissues, building on the foundation established by current research tools.

How can OR2M3 antibodies help elucidate the relationship between receptor structure and ligand specificity?

OR2M3 antibodies can serve as valuable tools for investigating structure-function relationships:

Conformational Studies:

• Conformation-specific antibodies could potentially distinguish between active and inactive receptor states

• Epitope mapping with antibody panels can identify critical functional domains

• Studies combining antibody binding with ligand competition assays can reveal structural changes upon activation

Structure-Function Analysis:

• Immunoprecipitation with OR2M3 antibodies followed by mass spectrometry can identify post-translational modifications affecting function

• Antibodies targeting the copper binding pocket could help elucidate metal ion coordination in ligand recognition

• Site-directed mutagenesis combined with antibody binding studies can map critical functional residues

Comparative Receptor Studies:

• OR2M3 is known to bind 3-Mercapto-2-methylpentan-1-ol (associated with onion odor)

• Antibody-based pull-down assays could help identify novel ligands by capturing receptor-ligand complexes

• Cross-family comparisons between OR2M3 and other olfactory receptors could reveal conserved binding mechanisms

These approaches may provide insights into not only OR2M3 function but also broader principles of olfactory receptor operation.

What methodological considerations are important when using OR2M3 antibodies in co-immunoprecipitation studies?

Co-immunoprecipitation (Co-IP) studies with OR2M3 antibodies require careful optimization:

Sample Preparation Challenges:

• Detergent selection is critical: Mild detergents (DDM, CHAPS) better preserve protein-protein interactions than stronger detergents (SDS, Triton X-100)

• Cross-linking considerations: Membrane protein interactions may require chemical cross-linking prior to lysis

• Buffer optimization: Ionic strength, pH, and divalent cation concentrations can significantly impact complex stability

• Receptor density: Work with tissues/cells expressing sufficient levels of native OR2M3 or consider heterologous expression systems

Technical Optimization:

• Antibody orientation: Consider whether to use the antibody as the capture reagent or to tag OR2M3 and use anti-tag antibodies

• Pre-clearing protocols: Reduce non-specific binding by pre-clearing lysates

• Washing stringency: Balance between preserving complexes and reducing background

• Elution conditions: Develop strategies that efficiently release complexes without contaminating the sample with antibody chains

Validation Approaches:

• Reciprocal Co-IP: Confirm interactions by immunoprecipitating with antibodies against the putative interacting partner

• Negative controls: Include isotype control antibodies and samples lacking OR2M3 expression

• Competitive peptide controls: Pre-incubation with immunizing peptide should abolish specific pull-down

These methodological considerations are particularly important given OR2M3's membrane localization and potential integration into larger signaling complexes.

How do available OR2M3 antibodies compare in terms of specificity and application versatility?

Based on the search results, two primary commercial OR2M3 antibodies are available with different characteristics:

When selecting between these antibodies, researchers should consider:

• The St John's Laboratory antibody offers broader species reactivity (human, rat, mouse)

• The Abbexa antibody has been validated for additional applications (Western blot, flow cytometry)

• Both antibodies target overlapping but not identical C-terminal regions

• The different purification strategies may impact specificity and background

For comprehensive studies, using both antibodies in parallel could provide complementary data and increased confidence in results.

What experimental design considerations are important when investigating potential non-olfactory functions of OR2M3?

Investigating OR2M3's potential functions beyond olfaction requires carefully designed experiments:

Expression Verification:

• Multi-method verification of expression: Combine antibody-based detection with RT-PCR and RNA-seq data

• Spatial resolution: Single-cell approaches to identify specifically which cell types express OR2M3

• Temporal dynamics: Assess expression changes during development or under different physiological conditions

Functional Assessment:

• Loss-of-function approaches: siRNA knockdown, CRISPR/Cas9 knockout, or antibody-mediated blockade

• Gain-of-function approaches: Heterologous expression or targeted activation

• Endogenous ligand identification: Building on known binding to 3-Mercapto-2-methylpentan-1-ol , screen for tissue-specific ligands

Physiological Context:

• Consider the findings with OR2L13 in platelets as a conceptual model

• Investigate potential signaling pathways, focusing on cAMP production (similar to OR2L13)

• Examine potential roles in disease contexts, based on knowledge that OR2M3 has a copper binding pocket that might be relevant in metal homeostasis disorders

Experimental Controls:

• Tissue-specific positive controls known to express OR2M3

• Related olfactory receptors as comparative controls

• Careful antibody validation to ensure specificity in non-olfactory tissues

The emerging understanding of olfactory receptors having functions beyond smell perception makes this an especially promising research direction.

What datasets and bioinformatic resources are available to complement OR2M3 antibody studies?

Researchers can leverage several bioinformatic resources to enhance OR2M3 antibody-based investigations:

Protein Databases and Resources:

• UniProt Entry: Q8NG83 (Primary AC), B9EH06, Q6IEY0 (Secondary ACs)

• KEGG: hsa:127062

• STRING: 9606.ENSP00000389625

• Reactome: R-HSA-9752946

Expression Databases:

• Human Protein Atlas for tissue expression profiles

• ENCODE for regulatory elements and transcription factor binding sites

• GTEx for expression quantitative trait loci (eQTLs)

• Single Cell Expression Atlas for cell-type specific expression patterns

Structural Resources:

• AlphaFold or RoseTTAFold predicted structures

• GPCRdb for comparative analysis with other G-protein coupled receptors

• Molecular docking platforms to model interactions with 3-Mercapto-2-methylpentan-1-ol

Data Integration Tools:

• PathwayCommons for potential signaling pathway integration

• The Pharos platform (Target Development Level: Tbio) provides comprehensive knowledge evaluation metrics for OR2M3

• Specific knowledge areas for OR2M3 include cell line (0.59), tissue (0.55), protein domain (0.41), pathway (0.32), and cell type or tissue (0.31)

These resources can guide experimental design and help interpret results from antibody-based studies.

What quality control measures should be implemented when evaluating OR2M3 antibody lot-to-lot variability?

Polyclonal antibodies like those available for OR2M3 are particularly susceptible to lot-to-lot variability. Implementing robust quality control measures is essential:

Pre-Experimental Validation:

• Western blot qualification: Confirm expected molecular weight (34.8 kDa) and banding pattern

• Peptide competition assay: Pre-incubation with immunizing peptide should eliminate specific signal

• Dilution series comparison: Perform side-by-side testing of old and new lots at multiple dilutions

• Positive control testing: Use consistent positive controls to assess relative sensitivity

Standardization Approaches:

• Create internal reference standards: Aliquot and freeze positive control lysates/samples

• Develop quantitative metrics: Signal-to-noise ratio, EC50 values, or staining intensity scores

• Document lot numbers and certificate of analysis details

• Consider preparing master mixes of working dilutions for long-term studies

Documentation and Reporting:

• Maintain detailed records of antibody performance across applications

• Report lot numbers in publications and internal protocols

• Consider parallel testing of multiple antibodies targeting different OR2M3 epitopes

• Implement digital image analysis for objective comparison of staining patterns

These measures are especially important for OR2M3 research where the relatively limited body of literature means fewer external benchmarks for antibody performance.

What are the recommended best practices for validating novel findings obtained using OR2M3 antibodies?

When reporting novel findings with OR2M3 antibodies, researchers should implement a multi-tiered validation approach:

Technical Validation:

• Multiple antibody approach: Confirm findings using at least two different antibodies targeting distinct OR2M3 epitopes

• Multiple technique confirmation: Verify protein detection using complementary methods (IF, WB, ELISA)

• Controls: Include appropriate positive and negative controls, including peptide competition and isotype controls

• Quantification: Implement objective quantification methods rather than relying solely on representative images

Biological Validation:

• Genetic manipulation: Confirm antibody specificity and biological findings using knockdown/knockout approaches

• Heterologous expression: Test antibody specificity in overexpression systems

• Functional correlation: Connect antibody-detected expression with functional readouts

• Cross-species validation: When appropriate, confirm findings across species using the human/rat/mouse reactive antibody

Reporting Transparency:

• Detailed methods documentation: Include complete antibody information (source, catalog number, lot number, dilution)

• Raw data availability: Provide access to unprocessed images and full-length blots

• Protocol sharing: Make detailed protocols available through repositories or supplementary materials

• Limitation acknowledgment: Clearly state any limitations or caveats of the antibody-based approach

These best practices ensure that findings with OR2M3 antibodies are robust, reproducible, and advance our understanding of this olfactory receptor's biology.

How should researchers integrate multiple methodologies to build a comprehensive understanding of OR2M3 function?

A comprehensive understanding of OR2M3 function requires integration of multiple methodological approaches:

Complementary Detection Methods:

• Antibody-based protein detection (IF, WB, ELISA, FCM)

• Transcript analysis (RT-PCR, RNA-seq, in situ hybridization)

• Reporter systems for live-cell monitoring of receptor activity

• Mass spectrometry for protein identification and quantification

Functional Characterization:

• Ligand binding studies building on known interaction with 3-Mercapto-2-methylpentan-1-ol

• Signaling pathway analysis examining G-protein coupling and downstream effectors

• Cell-specific functional assays based on tissue expression patterns

• In vivo models to assess physiological relevance

Structural Insights:

• Computational modeling of the copper binding pocket

• Conformational antibodies to distinguish activation states

• Mutation analysis of key structural features

• Comparison with related olfactory receptors

Data Integration Frameworks:

• Systems biology approaches linking receptor expression to broader cellular networks

• Multi-omics integration connecting genomic, transcriptomic, and proteomic data

• Pathway modeling to place OR2M3 in relevant signaling contexts

• Comparative analysis with other olfactory receptors with non-canonical functions (e.g., OR2L13)